A phase II trial of lenvatinib in patients with metastatic colorectal cancer after standard chemotherapy (NCCH1503,Lemon trial)
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Interventions: 24mg of lenvatinib is orally taken once daily. Primary outcome(s): Disease control rate Study Design: Single arm Non-randomized
创建时间：
2016-08-15
